top of page
Browse by category
Search
Popularity of GLP-1s among privately insured patients may worsen disparities
Publicly insured US individuals who are most likely to benefit from new drugs for diabetes and obesity are less likely to get them than...
Specialised weight navigation programme increases a patient’s chances of receiving at least one evidence-based weight-management treatment and resulted in more weight loss
Giving high-risk patients access to an obesity specialist through their regular primary care clinic increased their chances of receiving...
Study to analyse the real-world effectiveness of GLP-1 weight-loss drugs and inequities in access to these medications
The Robert Wood Johnson Foundation has awarded a grant to Andrew Stokes, associate professor of global health, Boston University School...
Browse by tag
bottom of page